SynBioVen
Overview
SynBioVen is an independent investment vehicle founded in 2022, dedicated to supporting the next generation of synthetic and engineering biology scientists, founders, and start-ups in the United Kingdom. It provides Proof of Concept (PoC), pre-seed, and seed funding, along with technical expertise, strategic mentorship, and access to facilities like the London Biofoundry. The firm focuses on sectors including Life Sciences, High Tech, Environment Tech, healthcare, agriculture, and clean technology.
Portfolio Companies
10
Website
synbioven.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Valink Therapeutics | Nov 2023 | Seed | Co-investor |
| Generare | Oct 2024 | Seed | Co-investor |
| Colorifix | May 2022 | Series B | Co-investor |
| Eden Bio | Nov 2022 | Seed | Lead |
| Multus Biotechnology | Jan 2023 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is SynBioVen based?
SynBioVen is headquartered in London, England, United Kingdom.
When was SynBioVen founded?
Founding year information for SynBioVen is not publicly available.
How many portfolio companies does SynBioVen have?
SynBioVen has 10 portfolio companies in Caplight's dataset.
What are some companies in SynBioVen's portfolio?
Portfolio companies visible on Caplight include Valink Therapeutics, Generare, Colorifix, Eden Bio, Multus Biotechnology.
What was SynBioVen's most recent investment shown here?
SynBioVen's most recent investment in this portfolio sample was in Generare in 2024.
What sectors does SynBioVen focus on?
SynBioVen focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does SynBioVen focus on?
SynBioVen typically invests at the Early stage.
What is SynBioVen's AUM?
SynBioVen's assets under management are estimated between $18.8M and $18.8M.